scispace - formally typeset
C

Corinne Frere

Researcher at University of Paris

Publications -  74
Citations -  2059

Corinne Frere is an academic researcher from University of Paris. The author has contributed to research in topics: Acute coronary syndrome & Cancer. The author has an hindex of 18, co-authored 74 publications receiving 1309 citations. Previous affiliations of Corinne Frere include French Institute of Health and Medical Research & Institute of Chartered Accountants of Nigeria.

Papers
More filters
Journal ArticleDOI

2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.

Dominique Farge, +98 more
- 01 Oct 2019 - 
TL;DR: The 2019 International Initiative on Thrombosis and Cancer clinical practice guidelines, which are based on a systematic review of the literature published up to December, 2018, are presented along with a Grading of Recommendations Assessment Development and Evaluation scale methods.
Journal ArticleDOI

Tissue damage from neutrophil-induced oxidative stress in COVID-19.

TL;DR: It is suggested that free radical scavengers could be beneficial for the most vulnerable patients with COVID-19, because of how the excessive release of reactive oxygen species by neutrophils may perpetuate red blood cell dysfunction, thrombosis and tissue damage in severe cases of COIDs.
Journal ArticleDOI

Predictive value of post-treatment platelet reactivity for occurrence of post-discharge bleeding after non-ST elevation acute coronary syndrome. Shifting from antiplatelet resistance to bleeding risk assessment?

TL;DR: In this article, the authors assessed prospectively the association between occurrence of post-discharge non-CABG-related TIMI major and minor bleeding and post-treatment platelet reactivity in patients with non-ST elevation acute coronary syndrome (NSTE ACS).
Journal ArticleDOI

High post-treatment platelet reactivity is associated with a high incidence of myonecrosis after stenting for non-ST elevation acute coronary syndromes.

TL;DR: After being correlated with recurrent ischemic events after stenting for N STE-ACS, the HPPR seems to be also a marker of increased risk of periprocedural MI for NSTE- ACS patients.